The fund is generally included in less than 2 deals every year. When the investment is from European regional development fund (ERDF) the average startup value is 1-5 millions dollars. The usual things for fund are deals in the range of 1 - 5 millions dollars. The real fund results show that this VC is 1 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2019.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Biopharma, Analytics. Among the various public portfolio startups of the fund, we may underline adsquare, Ibex Innovations, Avid Technology Group
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the European regional development fund (ERDF), startups are often financed by Northstar Ventures, North East Technology Fund, EASME - EU Executive Agency for SMEs. The meaningful sponsors for the fund in investment in the same round are Northeast Venture Fund ( NEVF ), Mercia Fund Managers, Scottish Investment Bank. In the next rounds fund is usually obtained by Target Partners, REV, NGP Capital.
Funds with similar focus
|Caxton Advantage Life Sciences Fund||New York, New York, United States|
|Changxin Xinxi||China, Jiangxi, Jiujiang|
|China-Belgium Direct Equity Investment Fund||-|
|Duchossois Capital Management||Chicago, Illinois, United States|
|FamilySearch||Salt Lake City, United States, Utah|
|Hangzhou Fuzhuo Investment Management||China, Hangzhou, Zhejiang|
|Hydrogen Capital Partners||Luxembourg, Luxembourg|
|Insigma Technology||New York, New York, United States|
|JL Company I LLC||-|
|KP Engineering||Texas, Tyler, United States|
|Phelps Dodge International Corporation||New York, New York, United States|
|RCM Business||Bhilwara, India, Rajasthan|
|Riceland HealthCare||Texas, United States, Winnie|
|Sarissa Capital Management||-|
|Score Capital||China, Shanghai|
|Singh Capital Partners||Maryland, Potomac, United States|
|Yahui Precision Medicine Fund||China, Yunnan, Zhaotong|
|$6M||16 Mar 2022||Besançon, Franche-Comte, France|
|$47K||26 Jan 2022||Riga, Latvia|
|$2M||23 Dec 2021||Bristol, England, United Kingdom|
|$1M||01 Dec 2021||Warsaw, Masovian Voivodeship, Poland|
Deep Neuron Lab
|$772K||28 Oct 2021||Berlin, Berlin, Germany|
|$1M||19 Oct 2021||Belfast, Northern Ireland, United Kingdom|
|$25K||12 Aug 2021||Athens, Attiki, Greece|
|$47K||06 Jul 2021||Riga, Latvia|
|$1M||28 May 2021||Neath Port Talbot, United Kingdom|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.